Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367,291,225
-
Total 13F shares
-
26,391,107
-
Share change
-
+1,061,638
-
Total reported value
-
$765,866,420
-
Put/Call ratio
-
322%
-
Price per share
-
$29.02
-
Number of holders
-
70
-
Value change
-
+$33,796,376
-
Number of buys
-
38
-
Number of sells
-
24
Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q1 2021
As of 31 Mar 2021 Legend Biotech Corp - COMMON STOCK (LEGN) had 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,391,107 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, Hudson Bay Capital Management LP, ALLIANCEBERNSTEIN L.P., FEDERATED HERMES, INC., CAPITAL INTERNATIONAL INC, Point72 Asset Management, L.P., Johnson & Johnson Innovation - JJDC, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Capital World Investors, and MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC.
This table shows 69 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.